Company Number: 14402890

Analysis Date: 2025-07-20 17:59 UTC

Financial Health Assessment Report for NUTRIWOLDS RAW LTD
As of Financial Year Ending 31 March 2025

---

1. Financial Health Score: D

Explanation:
NUTRIWOLDS RAW LTD currently exhibits significant financial distress. The company’s negative net assets and worsening working capital position signal underlying liquidity and solvency issues. While the firm is operationally active with employees, the balance sheet shows symptoms akin to a patient with a deteriorating vital sign profile, requiring urgent interventions to prevent further financial decline.

---

2. Key Vital Signs

Metric	Latest Value (£)	Interpretation
Net Assets (Shareholders’ Funds)	-135,739	Severe negative equity indicates liabilities exceed assets by a large margin—critical warning.
Net Current Assets (Working Capital)	-21,104	Negative working capital signals liquidity stress; current liabilities surpass current assets.
Current Assets	2,950	Very low cash and receivables to cover short-term obligations; weak cash flow position.
Current Liabilities	114,735	High short-term liabilities increase pressure on cash reserves; risk of cash flow crunch.
Long-term Creditors	114,735	Significant long-term debt further burdens financial stability.
Employee Count	11	Moderate headcount for a micro-entity; payroll obligations may be a substantial expense.
Account Category	Micro	Simplified reporting requirements, but financial challenges remain significant.

---

3. Diagnosis: What the Numbers Reveal

• Liquidity Crisis: The company’s net current assets have plunged from a positive £31,098 (October 2023) to a negative £21,104 (March 2025). This is a red flag akin to a patient showing signs of dehydration—cash and short-term assets are insufficient to meet immediate liabilities.

• Solvency Concerns: Net assets shifted from positive £55,284 (Oct 2023) to a deeply negative £135,739 (Mar 2025). This indicates accumulated losses or increasing debts are eroding shareholder equity, threatening long-term viability—the financial equivalent of organ failure warning in a health check.

• Absence of Fixed Assets: No fixed assets reported, suggesting no tangible collateral or investment in long-term resources. This limits borrowing options and reduces asset backing.

• Debt Burden: Both current and long-term liabilities are substantial relative to assets, indicating high gearing and financial strain. This is a symptom of over-leverage, increasing risk of insolvency if cash flow does not improve.

• Management Changes: Multiple director changes in 2023-2024 could indicate governance or strategic instability, which may compound financial distress.

• Operational Activity: Despite financial stress, the company employs 11 people, indicating ongoing operations but also sustained fixed costs.

---

4. Recommendations: Prescriptions for Financial Wellness

1. Immediate Cash Flow Management

   • Conduct a thorough cash flow forecast to identify timing gaps and avoid payment defaults.
   • Prioritize collection of receivables and negotiate extended payment terms with suppliers to ease working capital pressure.

2. Debt Restructuring and Capital Injection

   • Engage creditors to restructure or refinance short- and long-term liabilities to reduce immediate cash outflows.
   • Consider raising new equity or shareholder loans to shore up negative net assets and restore financial stability.

3. Cost Control and Operational Efficiency

   • Review staffing levels and overheads closely to align costs with revenue generation capability.
   • Implement tighter budget controls and monitor expenses rigorously to avoid further erosion of reserves.

4. Strategic Review

   • Analyze business model viability and product profitability, especially given the niche in prepared pet foods.
   • Explore diversification or partnerships to enhance revenue streams and reduce financial stress.

5. Governance Stability

   • Stabilize management team with clear roles and responsibilities to build confidence among investors and creditors.
   • Enhance financial reporting and controls to detect early symptoms of financial distress.

---

Medical Analogy Summary

NUTRIWOLDS RAW LTD is currently exhibiting “symptoms of financial distress” characterized by a “weak pulse” in liquidity and “organ failure” in solvency. The company’s financial “vital signs” indicate it is in a precarious state, requiring immediate “treatment” through cash flow management, debt restructuring, and operational cost control to avoid “collapse.” Without prompt and decisive action, the prognosis is poor.

---